The group’s principal activities include the research, development and marketing of novel therapies to treat inflammatory and infectious diseases and disorders of the upper respiratory system. The group markets its product under the tradename SinoFresh(TM) Nasal Mist. The group operates from the United States. In the year 2005, the group’s total revenue was $2,939,189.
